Article Details

Bain Capital-backed Emcure Pharma strengthens its board ahead of Rs4,000 cr IPO

Retrieved on: 2021-07-27 13:41:15

Tags for this article:

Click the tags to see associated articles and topics

Bain Capital-backed Emcure Pharma strengthens its board ahead of Rs4,000 cr IPO. View article details on hiswai:

Excerpt

Emcure is engaged in gynaecology, blood-related and HIV antiviral therapy areas. It is also developing India's first mRNA vaccine for covid-19 using its ...

Article found on: www.livemint.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up